OOIR: Observatory of International Research

Papers

(The median citation count of Ophthalmology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045	639
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data	403
Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients	275
International Classification of Retinopathy of Prematurity, Third Edition	260
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration	220
HAWK and HARRIER	200
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab	192
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab	178
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up	167
Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study	155
Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients	152
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration	151
Photovoltaic Restoration of Central Vision in Atrophic Age-Related Macular Degeneration	141
Primary Open-Angle Glaucoma Preferred Practice Pattern®	137
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration	136
Genetic Basis of Inherited Retinal Disease in a Molecularly Characterized Cohort of More Than 3000 Families from the United Kingdom	125
Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic	111
Multifocal and Extended Depth-of-Focus Intraocular Lenses in 2020	110
The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study	110
Deep Learning Approaches Predict Glaucomatous Visual Field Damage from OCT Optic Nerve Head En Face Images and Retinal Nerve Fiber Layer Thickness Maps	103
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration	98
Update on Intraocular Lens Power Calculation Study Protocols	97
Polypoidal Choroidal Vasculopathy	97
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis	96
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration	92

Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs — An Extension of the Modified Airlie House Classification	92
The Risks and Benefits of Myopia Control	91
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma	89
Application of Automated Quantification of Fluid Volumes to Anti–VEGF Therapy of Neovascular Age-Related Macular Degeneration	87
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)	82
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease	81
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset	80
COVID-19 Quarantine Reveals That Behavioral Changes Have an Effect on Myopia Progression	78
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19	78
Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children	74
Ganglion Cell Complex Thickness and Macular Vessel Density Loss in Primary Open-Angle Glaucoma	73
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout	73
Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure	73
Prevalence of Keratoconus Based on Scheimpflug Imaging	71
Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty	71
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration	70
Intraocular Lens Implantation in the Absence of Zonular Support: An Outcomes and Safety Update	66
Academic Ophthalmology during and after the COVID-19 Pandemic	64
Intraocular Lens Power Formulas, Biometry, and Intraoperative Aberrometry	64
Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2	63
Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration	63
Randomized Clinical Trial Comparing Femtosecond LASIK and Small-Incision Lenticule Extraction	62
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment	61
Primary Retinal Detachment Outcomes Study Report Number 2	61
Trends in Glaucoma Surgeries Performed by Glaucoma Subspecialists versus Nonsubspecialists on Medicare Beneficiaries from 2008 through 2016	61
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)	59
Comparison of Myopic Progression before, during, and after COVID-19 Lockdown	59
Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning	58
Evolution of the Prevalence of Myopia among Taiwanese Schoolchildren	58
Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children	52
Increased Time Outdoors Is Followed by Reversal of the Long-Term Trend to Reduced Visual Acuity in Taiwan Primary School Students	51
The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment	51
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy	51
Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT	51
Socioeconomic and Demographic Disparities in the Use of Telemedicine for Ophthalmic Care during the COVID-19 Pandemic	51
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children	50
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis	49
Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen	48
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial	47
Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia	46
Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration	46
Longitudinal Macular Structure–Function Relationships in Glaucoma	46
Can Structural Grading of Foveal Hypoplasia Predict Future Vision in Infantile Nystagmus?	46
Three-Year Findings of the HORIZON Trial	46
Updating the Staging System for Diabetic Retinal Disease	46
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease	46
Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom	45
Primary Angle-Closure Disease Preferred Practice Pattern®	45
The State of Ophthalmology Medical Student Education in the United States: An Update	44
Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients	44

Detection of Progressive Glaucomatous Optic Nerve Damage on Fundus Photographs with Deep Learning	44
Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic	44
The Bidirectional Relationship between Vision and Cognition	44
Cataract in the Adult Eye Preferred Practice Pattern®	43
Autologous Retinal Transplantation for Primary and Refractory Macular Holes and Macular Hole Retinal Detachments	43
Time Outdoors in Reducing Myopia	43
Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study	43
Predicting the Prognosis of Fuchs Endothelial Corneal Dystrophy by Using Scheimpflug Tomography	42
Private Equity in Ophthalmology and Optometry	42
Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy	42
Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes	42
Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration	42
Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine	42
Assessing Glaucoma Progression Using Machine Learning Trained on Longitudinal Visual Field and Clinical Data	42
Intraocular Lens Power Calculations in Eyes with Previous Corneal Refractive Surgery	42
OCT Angiography for the Diagnosis of Glaucoma	41
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery	41
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe	41
Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine	40
OCT Angiography Artifacts in Glaucoma	40
Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma	40
Foundational Considerations for Artificial Intelligence Using Ophthalmic Images	40
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial	39
Anti–Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration	39
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2	39
Ranibizumab or Aflibercept for Diabetic Macular Edema	38
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1	38
Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens	38
A Deep Learning Model for Segmentation of Geographic Atrophy to Study Its Long-Term Natural History	38
Evaluation of a Deep Learning–Derived Quantitative Retinopathy of Prematurity Severity Scale	38
Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry	38
Seven-Year Follow-up of Gene Therapy for Leber’s Hereditary Optic Neuropathy	38
Pseudophakic Dysphotopsia	37
Multifocal and Accommodating Intraocular Lenses for the Treatment of Presbyopia	37
Global Retinoblastoma Treatment Outcomes	37
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema	37
Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT)	37
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features	37
Disparities in Vision Health and Eye Care	36
Sex-Specific Differences in Circumpapillary Retinal Nerve Fiber Layer Thickness	36
American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis	36
Uveitis in Juvenile Idiopathic Arthritis	36
Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)	36
Incidence Rate of Herpes Zoster Ophthalmicus	36
The Economic Burden of Vision Loss and Blindness in the United States	36
Cost-Utility Analysis of Glaucoma Medication Adherence	36
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up	35
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration	35
Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus	35
An Intraocular Pressure Polygenic Risk Score Stratifies Multiple Primary Open-Angle Glaucoma Parameters Including Treatment Intensity	35
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma	35
COVID-19 and the Ophthalmology Match	35
Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease	34
Ophthalmology Departments Remain Among the Least Diverse Clinical Departments at United States Medical Schools	34
The Effect of Tube Location on Corneal Endothelial Cells in Patients with Ahmed Glaucoma Valve	34
Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis	34
Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy	34
Recommendations for Standardization of Images in Ophthalmology	34
Biallelic CPAMD8 Variants Are a Frequent Cause of Childhood and Juvenile Open-Angle Glaucoma	33
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration	33
The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study	33
Prevalence and Pattern of Geographic Atrophy in Asia	33
Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality	33
Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes	33
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice	33
Small-Incision Lenticule Extraction (SMILE) for the Correction of Myopia with Astigmatism	32
Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma	32
Intraocular Pressure, Glaucoma, and Dietary Caffeine Consumption	32
Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study	32
Multimodal Machine Learning Using Visual Fields and Peripapillary Circular OCT Scans in Detection of Glaucomatous Optic Neuropathy	31
Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2	31
Prevalence and Risk Factors of Tamoxifen Retinopathy	31
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma	31
Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area	31
Endophthalmitis Rate in Immediately Sequential versus Delayed Sequential Bilateral Cataract Surgery within the Intelligent Research in Sight (IRIS®) Registry Data	31
Bilateral Same-Day Cataract Surgery: An Idea Whose Time Has Come #COVID-19	31
Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children	31
Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning	31
Demographics of a Large International Population of Patients Affected by Leber’s Hereditary Optic Neuropathy	30
Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema	30

Development of a Genotype Assay for Age-Related Macular Degeneration	30
Characteristics of Orbital Floor Fractures in the United States from 2006 to 2017	30
The Global Extent of Undetected Glaucoma in Adults	30
Spectral-Domain OCT–Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration	30
Aqueous Humor Is Superior to Blood as a Liquid Biopsy for Retinoblastoma	29
Authorship Gender Composition in the Ophthalmology Literature from 2015 to 2019	29
Management and Outcomes for Neovascular Age-Related Macular Degeneration	29
The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections	29
Delayed Retinal Breaks and Detachments after Acute Posterior Vitreous Detachment	29
Characterization of Facial Trauma Associated with Standing Electric Scooter Injuries	29
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019	29
Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population	29
X-Linked Retinoschisis	29
Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States	29
COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses	29
Autosomal Recessive Bestrophinopathy	28
Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity	28
Gender Compensation Gap for Ophthalmologists in the First Year of Clinical Practice	28
Coping with COVID-19: An Italian Perspective on Corneal Surgery and Eye Banking in the Time of a Pandemic and Beyond	28
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid	28
Immune Checkpoint Inhibitor-Associated Optic Neuritis	28
Myopia Prevalence and Ocular Biometry Features in a General Japanese Population	27
Effect of Gas Tamponade on the Intraocular Lens Position and Refractive Error after Phacovitrectomy	27
Symptomatic COVID-19 in Eye Professionals in Wuhan, China	27
Beyond Performance Metrics	27
Incidence and Early Course of Retinopathy of Prematurity	27
Genotypic and Phenotypic Spectrum of Foveal Hypoplasia	26
Diabetic Retinopathy Screening Using Smartphone-Based Fundus Imaging in India	26
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry	26
Ocular Symptoms among Nonhospitalized Patients Who Underwent COVID-19 Testing	26
Transepithelial versus Epithelium-off Corneal Collagen Cross-linking for Corneal Ectasia	26
How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country	26
Postoperative Endophthalmitis in Immediate Sequential Bilateral Cataract Surgery	26
Interventions for Indirect Traumatic Optic Neuropathy	25
Intravitreal Pharmacotherapies for Diabetic Macular Edema	25
Intraocular Lenses	25
Treatment Patterns for Diabetic Macular Edema: An Intelligent Research in Sight (IRIS®) Registry Analysis	25
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration	25
Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial	25
Lighting a Pathway: The Minority Ophthalmology Mentoring Program	25
Time-Course Changes in Optic Nerve Head Blood Flow and Retinal Nerve Fiber Layer Thickness in Eyes with Open-angle Glaucoma	25
Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US	25
Living with COVID-19: A Perspective from New York Area Ophthalmology Residency Program Directors at the Epicenter of the Pandemic	25
Accuracy of Autorefraction in Children	25
Prevalence of Age-related Maculopathy	24
Vaccine-Associated Uveitis after COVID-19 Vaccination	24
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis	24
Interventions for the Management of Computer Vision Syndrome	24
Value of 10-2 Visual Field Testing in Glaucoma Patients with Early 24-2 Visual Field Loss	24
Cardiovascular Disease Predicts Structural and Functional Progression in Early Glaucoma	24
Aggressive Posterior Retinopathy of Prematurity	24
Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer Loss in a Large Clinical Population	24
Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®	24
Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness	23
Teprotumumab	23
Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery	23
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration	23
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma	23
Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy	23
Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis	23
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata	23
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma	23
Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids	23
Prevalence of Strabismus and Its Impact on Vision-Related Quality of Life	23
A Comparison of the Accuracy of 6 Modern Toric Intraocular Lens Formulas	23
Importance of Paravascular Vitreal Adhesions for Development of Myopic Macular Retinoschisis Detected by Ultra-Widefield OCT	22
DeepLensNet: Deep Learning Automated Diagnosis and Quantitative Classification of Cataract Type and Severity	22
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis	22
Explaining the Rationale of Deep Learning Glaucoma Decisions with Adversarial Examples	22
Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank	22
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries	22
Age-Related Eye Disease and Cognitive Function	22
Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis	22
Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma	22
Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration	22
Intense Pulsed Light for Meibomian Gland Disease	22
Intraocular Lens Power Calculation in Eyes with Previous Excimer Laser Surgery for Myopia	21
Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels	21
Vision Impairment and Blindness Prevalence in the United States	21
Challenges and Lessons for Managing Glaucoma during COVID-19 Pandemic: Perspectives from Asia	21
Effectiveness of an Ophthalmic Hospital-Based Virtual Service during the COVID-19 Pandemic	21
Face Masks and Bacterial Dispersion Toward the Periocular Area	21
Blood Pressure and Glaucomatous Progression in a Large Clinical Population	21
Matching the Patient to the Intraocular Lens	21
Using Social Media to Disseminate Ophthalmic Information during the #COVID19 Pandemic	21
Artificial Intelligence for Retinopathy of Prematurity	21
Patient Harm Due to Diagnostic Error of Neuro-Ophthalmologic Conditions	21
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial	20
Glaucoma-like Parapapillary Choroidal Microvasculature Dropout in Patients with Compressive Optic Neuropathy	20
Impact of Standardized Prescribing Guidelines on Postoperative Opioid Prescriptions after Ophthalmic Surgery	20
Ophthalmic Medication Expenditures and Out-of-Pocket Spending	20
Intraocular Lens Complications	20
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment	20
Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry	20
OCT Angiography Findings in Preclinical Alzheimer’s Disease: 3-Year Follow-Up	20